Xian Ming Zeng Ph D

Xian Ming Zeng Ph D is from Fort Lauderdale, Florida, United States. Xian-Ming is currently Chief Executive Officer at Transpire Bio, located in Florida, United States. In Xian-Ming's previous role as a Executive Vice President, Head of Inhalation and Complex Injectables R&D at Lupin, Xian-Ming worked in Coral Springs, Florida, USA until Oct 2021. Prior to joining Lupin, Xian-Ming was a Executive Vice President, Head of Inhalation R&D at Lupin and held the position of Executive Vice President, Head of Inhalation R&D at Miami/Fort Lauderdale Area, USA. Prior to that, Xian-Ming was a Senior Vice President, Inhalation R&D at Lupin Pharmaceuticals, based in South Florida, USA from Jun 2013 to Jul 2016. Xian-Ming started working as Vice President, Global Respiratory R&D at Teva Branded Pharmaceuticals R&D, Inc. in Miami, Florida in Feb 2012. From Nov 2006 to Feb 2012, Xian-Ming was Senior Director at Teva Pharmaceutical Industries. Prior to that, Xian-Ming was a Professor of Pharmaceutics, Director of Research at Medway School of Pharmacy, University of Kent, U.K. from Sep 2005 to Oct 2006.